The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery
- Conditions
- Colon CancerRectal CancerColon AdenocarcinomaRectal Adenocarcinoma
- Interventions
- Device: Monofix
- Registration Number
- NCT05872334
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
This clinical trial aims to evaluate the safety and feasibility of mid-line fascial suturing using MONOFIX sutures in patients undergoing minimally invasive surgery for colorectal cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- Colorectal adenocarcinoma
- Elective (or planned) curative surgery
- Laparoscopic surgery
- Midline incision less than 10 cm
- Previous laparotomy with midline incision more than 10cm.
- Systemic chemotherapy for any cause within the last 6 months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Monofix Monofix In patients who underwent laparoscopic colorectal cancer surgery, the fascial closure of the midline incision was performed using a running suture type with Monofix, one of the barbed sutures.
- Primary Outcome Measures
Name Time Method Incisional hernia 18 months from surgery Incisional hernia diagnosed by CT scan.
- Secondary Outcome Measures
Name Time Method Wound bleeding 1 month from surgery In cases where bleeding was visually observed from the wound or a hematoma was observed on the CT scan.
Wound dehiscence 1 month from surgery In cases where the fascial closure was incomplete, causing part of the abdominal organs to protrude outside the abdomen, requiring surgical treatment.
Wound infection 1 month from surgery In cases where microorganisms were identified in the wound culture results.
Trial Locations
- Locations (1)
Samsung Medical Center
🇰🇷Seoul, Gangnam, Korea, Republic of